TY - JOUR
T1 - Machine Learning Guided Design of High-Affinity ACE2 Decoys for SARS-CoV-2 Neutralization
AU - Chan, Matthew C.
AU - Chan, Kui K.
AU - Procko, Erik
AU - Shukla, Diwakar
N1 - Funding Information:
This work was supported by the C3.ai Digital Transformation Institute Research Award provided by C3.ai Inc. and Microsoft Corporation, NIH grant R35GM142745 and intramural funds of the University of Illinois Department of Chemical and Biomolecular Engineering to D.S., and NIH grant R43-AI162329 to E.P. and K.K.C.
Publisher Copyright:
© 2023 American Chemical Society.
PY - 2023/3/9
Y1 - 2023/3/9
N2 - A potential therapeutic strategy for neutralizing SARS-CoV-2 infection is engineering high-affinity soluble ACE2 decoy proteins to compete for binding to the viral spike (S) protein. Previously, a deep mutational scan of ACE2 was performed and has led to the identification of a triple mutant variant, named sACE22.v.2.4, that exhibits subnanomolar affinity to the receptor-binding domain (RBD) of S. Using a recently developed transfer learning algorithm, TLmutation, we sought to identify other ACE2 variants that may exhibit similar binding affinity with decreased mutational load. Upon training a TLmutation model on the effects of single mutations, we identified multiple ACE2 double mutants that bind SARS-CoV-2 S with tighter affinity as compared to the wild type, most notably L79V;N90D that binds RBD similarly to ACE22.v.2.4. The experimental validation of the double mutants successfully demonstrates the use of machine learning approaches for engineering protein-protein interactions and identifying high-affinity ACE2 peptides for targeting SARS-CoV-2.
AB - A potential therapeutic strategy for neutralizing SARS-CoV-2 infection is engineering high-affinity soluble ACE2 decoy proteins to compete for binding to the viral spike (S) protein. Previously, a deep mutational scan of ACE2 was performed and has led to the identification of a triple mutant variant, named sACE22.v.2.4, that exhibits subnanomolar affinity to the receptor-binding domain (RBD) of S. Using a recently developed transfer learning algorithm, TLmutation, we sought to identify other ACE2 variants that may exhibit similar binding affinity with decreased mutational load. Upon training a TLmutation model on the effects of single mutations, we identified multiple ACE2 double mutants that bind SARS-CoV-2 S with tighter affinity as compared to the wild type, most notably L79V;N90D that binds RBD similarly to ACE22.v.2.4. The experimental validation of the double mutants successfully demonstrates the use of machine learning approaches for engineering protein-protein interactions and identifying high-affinity ACE2 peptides for targeting SARS-CoV-2.
UR - http://www.scopus.com/inward/record.url?scp=85149039373&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149039373&partnerID=8YFLogxK
U2 - 10.1021/acs.jpcb.3c00469
DO - 10.1021/acs.jpcb.3c00469
M3 - Article
C2 - 36827526
AN - SCOPUS:85149039373
SN - 1520-6106
VL - 127
SP - 1995
EP - 2001
JO - Journal of Physical Chemistry B
JF - Journal of Physical Chemistry B
IS - 9
ER -